Use of three procoagulants in improving bleeding outcomes in the warfarin patient with intracranial hemorrhage.

@article{DeLoughery2017UseOT,
  title={Use of three procoagulants in improving bleeding outcomes in the warfarin patient with intracranial hemorrhage.},
  author={Emma P DeLoughery and Thomas G DeLoughery},
  journal={Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis},
  year={2017},
  volume={28 8},
  pages={612-616}
}
: When patients on anticoagulation present with intracranial bleeding, stopping the bleeding is paramount. Despite the availability of multiple options to reverse anticoagulation, no study has directly compared the effectiveness of the procoagulants recombinant activated factor VII (rFVIIa), the rFVIIa and 3-factor prothrombin complex concentrate (PCC… CONTINUE READING